Drug Profile
Research programme: anti-cancer antibodies - Symphogen
Alternative Names: Sym 014Latest Information Update: 07 Jun 2023
Price :
$50
*
At a glance
- Originator Symphogen
- Class Drug conjugates; Immunoconjugates; Monoclonal antibodies
- Mechanism of Action Immunomodulators; Protein tyrosine kinase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Cancer; Leukaemia